Citations Farokhnia, M., et al, "Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake," Journal of Clinical Investigation, March 6, 2025, doi: 10.1172/JCI188314 Hendershot CS et al, "Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial." JAMA Psychiatry, Feb
Patients with pre-existing kidney disease should discuss creatine use with their provider, and baseline kidney function testing with periodic monitoring is recommended
Each works a bit differently, but they all turn on the same biological pathway in the body
Compounded semaglutide and compounded tirzepatide are prepared by pharmacists in FDA-registered and inspected compounding pharmacies
Patients should be educated about red-flag features that require urgent assessment